LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
14.03
+0.12 (0.86%)
Apr 28, 2025, 4:00 PM EDT - Market closed
LENSAR Market Cap
LENSAR has a market cap or net worth of $165.41 million as of April 29, 2025. Its market cap has increased by 353.61% in one year.
Market Cap
165.41M
Enterprise Value
145.57M
1-Year Change
353.61%
Ranking
Category
Stock Price
$14.03
Market Cap Chart
Since October 2, 2020, LENSAR's market cap has increased from $78.01M to $165.41M, an increase of 112.04%. That is a compound annual growth rate of 17.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2025 | 165.41M | 59.30% |
| Dec 31, 2024 | 103.84M | 163.00% |
| Dec 29, 2023 | 39.48M | 21.00% |
| Dec 30, 2022 | 32.63M | -50.28% |
| Dec 31, 2021 | 65.63M | -14.91% |
| Dec 31, 2020 | 77.13M | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 787.80B |
| UnitedHealth Group | 382.29B |
| Johnson & Johnson | 373.78B |
| AbbVie | 340.25B |
| Novo Nordisk | 280.41B |
| Abbott Laboratories | 224.65B |
| AstraZeneca | 218.53B |
| Novartis AG | 214.73B |